146 related articles for article (PubMed ID: 32598267)
21. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and anticancer properties of novel benzophenone-conjugated coumarin analogs.
Lakshmi Ranganatha V; Zameer F; Meghashri S; Rekha ND; Girish V; Gurupadaswamy HD; Khanum SA
Arch Pharm (Weinheim); 2013 Dec; 346(12):901-11. PubMed ID: 24170414
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
24. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
25. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
26. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells.
Maleki EH; Bahrami AR; Sadeghian H; Matin MM
Toxicol In Vitro; 2020 Mar; 63():104745. PubMed ID: 31830504
[TBL] [Abstract][Full Text] [Related]
27. Molecular docking studies of fused coumarin derivatives as inhibitors of GlcN-6.
Govori S; Haziri A; Ademi K; Neziraj N
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Sep; 52(11):1041-1045. PubMed ID: 28737449
[TBL] [Abstract][Full Text] [Related]
28. In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.
Maruthanila VL; Elancheran R; Roy NK; Bhattacharya A; Kunnumakkara AB; Kabilan S; Kotoky J
Curr Comput Aided Drug Des; 2019; 15(1):89-96. PubMed ID: 30306879
[TBL] [Abstract][Full Text] [Related]
29. Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D
Sarhan MO; Abd El-Karim SS; Anwar MM; Gouda RH; Zaghary WA; Khedr MA
Molecules; 2021 Apr; 26(8):. PubMed ID: 33919867
[TBL] [Abstract][Full Text] [Related]
30. Molecular Dynamics Guided Receptor Independent 4D QSAR Studies of Substituted Coumarins as Anticancer Agents.
Patil R; Sawant S
Curr Comput Aided Drug Des; 2015; 11(1):39-50. PubMed ID: 26081557
[TBL] [Abstract][Full Text] [Related]
31. Facile Synthesis of Novel Coumarin Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study, ADMET Prediction and Toxicity Study.
Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Karnik KS; Nikalje APG
Molecules; 2017 Jul; 22(7):. PubMed ID: 28703783
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity, Docking Study of New Fluorinated Fused Pyrimidine Scaffold: Thermal and Microwave Irradiation Synthesis.
Alnaja AMA; Farghaly TA; El-Zahabi HSA; Shaaban MR
Med Chem; 2021; 17(5):501-518. PubMed ID: 31840613
[TBL] [Abstract][Full Text] [Related]
33. New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK.
Batran RZ; Dawood DH; El-Seginy SA; Ali MM; Maher TJ; Gugnani KS; Rondon-Ortiz AN
Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28787092
[TBL] [Abstract][Full Text] [Related]
34. Binding and molecular dynamics studies of 7-hydroxycoumarin derivatives with human serum albumin and its pharmacological importance.
Yeggoni DP; Gokara M; Manidhar DM; Rachamallu A; Nakka S; Reddy CS; Subramanyam R
Mol Pharm; 2014 Apr; 11(4):1117-31. PubMed ID: 24495045
[TBL] [Abstract][Full Text] [Related]
35. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.
Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P
Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
[TBL] [Abstract][Full Text] [Related]
39. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
40. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
